Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned

The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry.

FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned

We haven't written up this one. NPR has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at npr.org →

More in Health & Medicine

More from Saturday 1 August →